Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

LD50 was considered to be 5400 mg/kg bw (95% confidential limit 4500 - 6400 mg/kg) for males and females,5800 mg/kg (95% confidential limit = 5100 – 6600 mg/kg) for males and 3900 mg/kg (95% confidential limit = 3000 - 5000 mg/kg) forfemales, when Crl:CD® BR male and female rats were treated with N,N-dimethylglycinium chloride orally by gavage.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Justification for type of information:
Data is from publication
Qualifier:
according to guideline
Guideline:
other: as below
Principles of method if other than guideline:
Acute oral toxicity of N,N-dimethylglycinium chloride (2491-06-7) in rat.
GLP compliance:
not specified
Test type:
other: not specified
Limit test:
no
Specific details on test material used for the study:
- Name of test material (as cited in study report): N,N-dimethylglycinium Hydrochloride
- Molecular formula (if other than submission substance): C4H10ClNO2
- Molecular weight (if other than submission substance): 139.581 g/mol
- Substance type: Organic
Species:
rat
Strain:
other: Crl:CD® BR
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: No data
- Age at study initiation: young adult albino rats were taken for the study.
- Weight at study initiation: No data
- Fasting period before study: 17 to 20 hours
- Housing:
- Diet (e.g. ad libitum): No data
- Water (e.g. ad libitum): ad libitum
- Acclimation period: No data
Route of administration:
oral: gavage
Vehicle:
water
Remarks:
distilled
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 3000 and 5000 mg/kg for female and 5000 and 6500 mg/kg for male
- Amount of vehicle (if gavage): 20.00 ml/Kg
- Justification for choice of vehicle: distilled water
- Lot/batch no. (if required):not specified
- Purity:not specified

MAXIMUM DOSE VOLUME APPLIED:not specified

DOSAGE PREPARATION (if unusual): Test material was mixed in distilled water, pH then adjusted to 7.4 using a NaOH solution and administered at a dose volume of 20.00 ml/Kg for each animal.

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose:not specified
Doses:
Females – 3000, 5000, 7000 mg/kg
Male – 5000, 6000 and 7000 mg/kg
No. of animals per sex per dose:
Total = 30
5 female -3000 mg/kg
5 female - 5000 mg/kg
5 female - 7000 mg/kg
5 male - 5000 mg/kg
5 male - 6000 mg/kg
5 male - 7000 mg/kg
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: The animals were observed for clinical signs and mortality at 1, 2.5 and 4 hours after test material administration. Surviving animals were observed daily thereafter for 14 days for clinical signs and twice daily for mortality.
Weighing: All animals were weighed just before test material administration and again at Day 7 and 14.
- Necropsy of survivors performed: yes
- Other examinations performed: The animals were observed for clinical signs, body weight and gross pathology were examination.
Statistics:
A Computer Program for Estimating LD50 and its Confidence Limits Using a Modified Behrens-Reed-Muench Cumulant Method
Preliminary study:
not specified
Sex:
male/female
Dose descriptor:
LD50
Effect level:
5 400 mg/kg bw
Based on:
test mat.
95% CL:
4 500 - 6 400
Remarks on result:
other: 50 5 mortality observed
Sex:
male
Dose descriptor:
LD50
Effect level:
5 800 mg/kg bw
Based on:
test mat.
95% CL:
5 100 - 6 600
Remarks on result:
other: 50 % mortality observed
Sex:
female
Dose descriptor:
LD50
Effect level:
3 900 mg/kg bw
Based on:
test mat.
95% CL:
3 000 - 5 000
Remarks on result:
other: 50 % mortality observed
Mortality:
When treated with 7000 mg/kg bw, all male and female died within 2.5 to 4 hours.
When treated with 6000 mg/kg bw, 3 male died.
When treated with 5000 mg/kg bw, all female rats were died.
When treated with 3000 and 5000 mg/kg bw, no mortality were observed in male and female rats.
Clinical signs:
other: Hypoactivity, ataxia, diarrhea, brown-stained abdomen, red-stained face, dyspnea, circling movements, prostration and absence of pain reflex in rats were observed in treated rats.
Gross pathology:
Test substance centred around the gastrointestinal tract were observed in dead animals and no gross lesions were observed in the animals which surviving to the termination of the experimental phase.

 Table – Acute oral toxicity in rats

DOSE AS DMG

FREEBASE G/KG

1DOSE AS DMG

FREEBASE G/KG

 

NUMBER

DOSED

CUMULATIVE MORTALITY

HOUR

DAY

1

2.5

4

1

2

3

4

5

6

7-14

3

2.3

5F

0

0

0

0

0

0

0

0

0

0

5

3.8

5M

0

0

0

0

0

0

0

0

0

0

5

3.8

5F

0

0

0

5

5

5

5

5

5

5

6

4.6

5M

0

0

0

2

3

3

3

3

3

3

7

5.3

5M

0

1

5

5

5

5

5

5

5

5

7

5.3

5F

0

3

4

5

5

5

5

5

5

5

 

1 - Dose reflects content as DMG freebase equivalent calculated at 75.9% of the hydrochloride level.

Interpretation of results:
Category 5 based on GHS criteria
Conclusions:
LD50 was considered to be 5400 mg/kg bw (95% confidential limit 4500 - 6400 mg/kg) for males and females, 5800 mg/kg (95% confidential limit = 5100 – 6600 mg/kg) for males and 3900 mg/kg (95% confidential limit = 3000 - 5000 mg/kg) for females, when Crl:CD® BR male and female rats were treated with N,N-dimethylglycinium chloride orally by gavage.
Executive summary:

In a acute oral toxicity study, groups of five female and five male young adult albino Crl:CD® BR rats were treated with N,N-dimethylglycinium chloride at the concentration of 3000, 5000, 7000 mg/kg in Females and 5000, 6000 and 7000 mg/kg in Males.Each dose of test material was mixed in distilled water, pH then adjusted to 7.4 using a NaOH solution and administered at a dose volume of 20 ml/kg for each animal by gavage route.Animals were fasted17 to 20 hours prior to dosing. Water wasfully available at all times.The animals were observed for clinical signs and mortality at 1, 2.5 and 4 hours after test material administration. Surviving animals were observed daily thereafter for 14 days for clinical signs and twice daily for mortality. All animals were weighed just before test material administration and again at Day 7 and 14. All animals, whether dying during the study or euthanatized at study termination, were subjected to a gross necropsy examination and all abnormalities were reported. All male and female died within 2.5 to 4 hours at 7000 mg/kg bw, 3 male died at 6000 mg/kg bw, all female rats were died at 5000 mg/kg bw and no mortality were observed in male and female rats at 3000 and 5000 mg/kg bw. Hypoactivity, ataxia, diarrhea, brown-stained abdomen, red-stained face, dyspnea, circling movements, prostration and absence of pain reflex in rats were observed in treated rats. Weight gain was observed in animals which survive to the end of the observation period.Test substance centred around the gastrointestinal tract were observed in dead animals and no gross lesions were observed in the animals which surviving to the termination of the experimental phase. Therefore,LD50 was considered to be 5400 mg/kg bw (95% confidential limit 4500 - 6400 mg/kg) for males and females,5800 mg/kg (95% confidential limit = 5100 – 6600 mg/kg) for males and 3900 mg/kg (95% confidential limit = 3000 - 5000 mg/kg) forfemales, when Crl:CD® BR male and female rats were treated with N,N-dimethylglycinium chloride orally by gavage.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
5 400 mg/kg bw
Quality of whole database:
Data is Klimisch 2 and from peer- reviewed journal

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Acute oral toxicity:

In different studies,2-(dimethylamino)acetic acid hydrochloridehas been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in vivo experiments and estimated data in rodents, i.e. most commonly in rats for2-(dimethylamino)acetic acid hydrochloridealong with the study available on structurally similar read across substanceN,N-dimethylglycine (CAS no 1118-68-9)The predicted data using the OECD QSAR toolbox has also been compared with the experimental studies.

In a experimental study conducted by Kendallet al(International Journal of Toxicology, Volume: 1 issue: 3s, page 198, 1992), groups of five female and five male young adult albino Crl:CD® BR rats were treated with N,N-dimethylglycinium chloride at the concentration of 3000, 5000, 7000 mg/kg in Females and 5000, 6000 and 7000 mg/kg in Males.Each dose of test material was mixed in distilled water, pH then adjusted to 7.4 using a NaOH solution and administered at a dose volume of 20 ml/kg for each animal by gavage route.Animals were fasted17 to 20 hours prior to dosing. Water wasfully available at all times.The animals were observed for clinical signs and mortality at 1, 2.5 and 4 hours after test material administration. Surviving animals were observed daily thereafter for 14 days for clinical signs and twice daily for mortality. All animals were weighed just before test material administration and again at Day 7 and 14. All animals, whether dying during the study or euthanatized at study termination, were subjected to a gross necropsy examination and all abnormalities were reported. All male and female died within 2.5 to 4 hours at 7000 mg/kg bw, 3 male died at 6000 mg/kg bw, all female rats were died at 5000 mg/kg bw and no mortality were observed in male and female rats at 3000 and 5000 mg/kg bw. Hypoactivity, ataxia, diarrhea, brown-stained abdomen, red-stained face, dyspnea, circling movements, prostration and absence of pain reflex in rats were observed in treated rats. Weight gain was observed in animals which survive to the end of the observation period.Test substance centred around the gastrointestinal tract were observed in dead animals and no gross lesions were observed in the animals which surviving to the termination of the experimental phase. Therefore,LD50 was considered to be 5400 mg/kg bw (95% confidential limit 4500 - 6400 mg/kg) for males and females,5800 mg/kg (95% confidential limit = 5100 – 6600 mg/kg) for males and 3900 mg/kg (95% confidential limit = 3000 - 5000 mg/kg) forfemales, when Crl:CD® BR male and female rats were treated with N,N-dimethylglycinium chloride orally by gavage.

In another prediction done by SSS (2017) using the OECD QSAR toolbox with log kow as the primary descriptor, the acute oral toxicity was estimated for2-(dimethylamino) acetic acid hydrochloride. The LD50 was estimated to be 2676 mg/kg bw when rats were orally exposed with2-(dimethylamino) acetic acid hydrochloride.

Further suppurated by experimental study conducted by Kendall et al(International Journal of Toxicology, Volume: 1 issue: 3s, page(s): 199-199, 1982) on structurally similar read across substance N,N-dimethylglycine (CAS 1118-68-9),five female and five male young adult albino Crl:CD® BR rats were treated with N,N-dimethylglycine the in concentration of 3000 and 5000 mg/kg in Females and 5000 and 6500 mg/kg in Males orally by gavage.Each dose of test material was mixed in distilled water, pH then adjusted to 7.4 using a NaOH solution and administered at a dose volume of 20 ml/kg for each animal by gavage route.Animals were fasted17 to 20 hours prior to dosing. Water wasfully available at all times.The animals were observed for clinical signs and mortality at 1, 2.5 and 4 hours after test material administration. Animals were observed daily thereafter for 14 days for clinical signs and twice daily for mortality. All animals were weighed just before test material administration and again at Day 7 and 14. All animals were euthanatized at study termination and were subjected to a gross necropsy examination with all abnormalities being recorded.No deaths were observed in treated male and female rats. Hypoactivity, ataxia, diarrhea, brown-stained abdomen, red-stained face and brown-stained urogential area were observed in treated rats. Weight gain was observed in animals.Multiple opaque areas over the entire spleen were observed in one 3000 mg/kg bw treated female rat. No gross lesions were observed in other treated rats. Therefore, LD50 was considered to be > 6500 mg/kg bw for Males and > 5000 mg/kg bw for Females, when Crl:CD® BR male and female rats were treated with N,N-dimethylglycine orally by gavage.

This is suppurated by experimental study summarized by Hoornet al(Mutation Research, 222 (1989) 343-350) on structurally similar read across substance N,N-dimethylglycine (CAS 1118-68-9), rats were treated with N,N-dimethylglycine at the concentration of 7000 mg/kg bw. No mortality was observed in treated rats at 7000 gm/kg bw. Therefore, The LD50 was considered to be >7000 mg/kg bw, when rats were treated with N,N-dimethylglycine orally.

Again this is supported by experimental study given by U.S. National Library of Medicine (ChemIDplus, A TOXNET DATABASE, Lite Browse Advanced, 2017) on structurally similar read across substance N-Nitrososarcosine (CAS no: 13256-22-9),rats were treated with N-Nitrososarcosine at the concentration of 5000 mg/kg bw. No mortality was observedin treated rats.Therefore, LD50 was considered to be >5000 mg/kg bw, when rats were treated with N-Nitrososarcosine (CAS no: 13256-22-9) orally.

Thus, based on the above studies and predictions on2-(dimethylamino)acetic acid hydrochlorideand its read across substances, it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation,2-(dimethylamino)acetic acid hydrochloridecan be classified as category V of acute oral toxicity.

Justification for classification or non-classification

Based on the above studies and predictions on2-(dimethylamino)acetic acid hydrochlorideand its read across substances, it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation,2-(dimethylamino)acetic acid hydrochloridecan be classified as category V of acute oral toxicity.